ASweetLife Team
ASweetLife Team

Bristol-Myers Logo

Type 2 Diabetes Drug ONGLYZA Approved for Sale in Europe

The European Commission has approved Bristol-Myers Squibb Company and AstraZeneca's ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycemic) control in adult patients with type 2 diabetes...
0 Shares
Running

Know Which Way You’re Going

Exercising with diabetes is complicated and although it's generally a good thing, it can make diabetes management more difficult (Catherine Price attests to this). ASweetLife's resident marathoner, Michael Aviad, found a great tip on Hypoactive.org that can help prevent exercise-related diabetes problems: test twice.
0 Shares
Diapep277

Positive Results for DiaPep277 Type 1 Diabetes Treatment in Phase 3 Study

Andromeda Biotech has announced positive initial results from a pivotal phase III clinical study of type 1 diabetes treatment, DiaPep227. The 24-month randomized, placebo-controlled study was designed to assess the safety and efficacy of DiaPep277, a novel immunotherapeutic agent for the treatment of newly diagnosed patients with type 1 diabetes...
0 Shares

Little Things We’re Grateful For

It's almost Thanksgiving, the time of year when we, like many others, focus on how grateful we are for the good things in life. Mike and I are incredibly grateful for the life we share and for the family we've created together. Diabetes does take a toll on us, but overall we're doing okay. We're not complaining.
0 Shares

Homemade Ricotta

We’re very grateful to Denise Woodward of the wonderful food blog, Chez Us, for sharing this recipe with us during Diabetes Awareness Month. …
0 Shares
PositiveID - logo

FDA Clears PositiveID’s iglucose, A Wireless Communication Diabetes Management System

The U.S. Food and Drug Administration (FDA) granted PositiveID Corporation clearance for its iglucose(TM) mobile health system for diabetes management. iglucose uses mobile technology to revolutionize the way individuals with diabetes manage their condition. By seamlessly communicating glucose readings from data-capable glucometers to the iglucose diabetes management portal, this important data can be shared with family members, caregivers and healthcare professionals...
0 Shares

FDA approves the t:slim, Tandem Diabetes Care Innovative Insulin Pump

The U.S. Food and Drug Administration (FDA) has granted Tandem Diabetes Care clearance to market the t:slim™ Insulin Delivery System (t:slim). This new full-featured pump is the first-ever with a color touch screen, and is the smallest insulin pump system currently available. The t:slim is one of the first insulin pumps to be cleared under the FDA’s new Infusion Pump Improvement Initiative...
0 Shares